Novotech has robust relationships with investigators allowing to quickly identify the best sites for liver disease clinical studies. Over the last 25 years, Novotech has provided high-quality Liver disease CRO services to numerous biotechnology companies using an approach adapted to the biotech model. 

Novotech experience in Liver diseases trials

Novotech has conducted over 70 trials in liver diseases including the following indications:

  • Hepatitis B (HBV)
  • Hepatitis C (HCV)
  • Hepatocellular carcinoma (HCC) and bile duct malignancies
  • Non-Alcoholic Steatohepatitis (NASH)
  • Non-Alcoholic Fatty Liver Disease (NAFLD)
  • Liver Transplant